We sought additional evidence that tumors with elevated TPX2 expression demonstrate an increased incidence of p53 mutation, and analyzed the provisional invasive breast carcinoma cohort within the The Cancer Genome Atlas (TCGA) [46, 47]. Here, TPX2 is linked to invasive breast carcinoma.